Share on StockTwits

Skyline Medical (NASDAQ:SKLN) COO David O. Johnson bought 14,300 shares of the stock on the open market in a transaction that occurred on Wednesday, August 27th. The shares were purchased at an average cost of $0.14 per share, with a total value of $2,002.00. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link.

Skyline Medical (NASDAQ:SKLN) traded up 3.71% on Monday, hitting $0.1399. 55,500 shares of the company’s stock traded hands. Skyline Medical has a 52 week low of $0.106 and a 52 week high of $0.44. The stock’s 50-day moving average is $0.13 and its 200-day moving average is $0.16. The company’s market cap is $31.2 million.

Skyline Medical Inc, formerly BioDrain Medical, Inc, is an early stage medical device company. The Company owns patent rights to its products and will distribute its products to medical facilities where bodily and irrigation fluids produced during surgical procedures must be contained, measured, documented, and disposed.

Receive News & Ratings for Skyline Medical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Skyline Medical Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.